首页 | 本学科首页   官方微博 | 高级检索  
检索        


The Promise of Improving Hepatocellular Carcinoma Treatment Responses through Translational Device Testing
Institution:1. Department of Radiology, Hanoi Medical University Hospital, Hanoi, Vietnam;2. Department of Surgery, Hanoi Medical University Hospital, Hanoi, Vietnam;3. Department of Diagnostic Radiology, Keio University, Tokyo, Japan;4. Department of Respiratory Medicine, Hanoi French Hospital, 1 Phuong Mai St., Dong Da District, 10000 Hanoi, Vietnam;1. Department of Ultrasound, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China;2. Department of Interventional Therapy, Shenzhen People’s Hospital, 2nd Clinical Medical College of Jinan University, Shenzhen, China;3. Department of Interventional Therapy, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People’s Hospital, Shenzhen 518035, China;4. Department of Radiology, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People’s Hospital, Shenzhen 518035, China;5. Biotherapy Center, Fuda Cancer Hospital of Jinan University, Guangzhou, China;6. Department of Oncology, Fuda Cancer Hospital of Jinan University, Guangzhou, China;7. Department of Radiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China;1. Department of Biomedical Engineering, Imaging Institute, Cleveland Clinic, Cleveland, Ohio;2. Department of Radiology, Imaging Institute, Cleveland Clinic, 2625 Butternut Lane, Pepper Pike, Cleveland, OH 44124;3. John Carroll University, University Heights, Ohio;1. Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016;2. Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;3. Department of Radiology, Virginia Tech Carilion School of Medicine, Carilion Clinic, Roanoke, Virginia;1. Duke University School of Medicine, Durham, North Carolina 27710;2. Vascular and Interventional Specialists, Charlotte Radiology, Charlotte, North Carolina;3. Department of Radiology, Division of Interventional Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;4. Department of Radiology, Division of Interventional Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC;1. Palo Alto Medical Foundation, Mountian View, California;2. Merit Medical Systems, Inc, 1600 W Merit Pkwy, South Jordan, UT, 80495;3. Alizée Pathology, LLC, Thurmont, Maryland
Abstract:
Keywords:HCC"}  {"#name":"keyword"  "$":{"id":"kwrd0015"}  "$$":[{"#name":"text"  "_":"hepatocellular carcinoma  HFIRE"}  {"#name":"keyword"  "$":{"id":"kwrd0025"}  "$$":[{"#name":"text"  "_":"high-frequency irreversible electroporation  LRT"}  {"#name":"keyword"  "$":{"id":"kwrd0035"}  "$$":[{"#name":"text"  "_":"locoregional therapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号